Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes

Depression Clinical Trial

— Patient Portal  

Official title:

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence, Satisfaction, and Outcomes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04646681
• Other study ID #: 201805861
• Status: Completed
• Phase: N/A
• Start date: March 31, 2021
• Est. completion date: April 30, 2022

Study information

• Verified date: June 2022
• Source: University of Iowa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to learn how best to use patient portals to help improve the treatment of mood disorders.

Description:

This study is being done in 3 phases. First 2 phases were observational with total enrollment of 300 subjects. The final 3rd phase is interventional and we are anticipating to enroll 50 subjects. It is described below. Patients being treated for depressive symptoms at the University of Iowa, Department of Psychiatry are invited to participate. Participants will complete a remote (phone or video) visit. After being informed about the study and potential risks, those who consent to being in the study will be assigned to one of two groups. They will complete an online survey and receive some basic training on patient portals. After the visit. both groups will be followed for 6 months. Depending on their group assignment, they will complete: - two to five phone calls with a study team member and - two to five online questionnaires

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: April 30, 2022
• Est. primary completion date: April 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

• English speaking,
• PHQ-9 score of 10 or higher (questions 1-8 only),
• Taking medication for depressive symptoms,
• 1 or more appointments scheduled or planned with University of Iowa psychiatry provider in next 6 months,
• Home computer w/internet access,
• MyChart (University of Iowa Healthcare's patient portal) account/MyChart enrollment

Exclusion Criteria:

• Psychotic disorder/symptoms,
• Current substance use disorders (other than alcohol, tobacco, marijuana),
• Active suicidal ideation within past 1 year,
• Cognitive impairment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• ConnectCare
increased monitoring between clinical mental health visits

Locations

Country	Name	City	State
United States	University of Iowa Carver College of Medicine, Dept. of Psychiatry	Iowa City	Iowa

Sponsors (1)

Lead Sponsor	Collaborator
Carolyn L Turvey

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Health Questionnaire (PHQ-9)	measures the severity of depression symptoms	Once per month for 6 months